Article
Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
The pharmacogenomics journal - 1 Oct 2012
Costalonga E F, Antonini S R R, Guerra G, Coletta R R D, Franca M M, Braz A F, Mendonca B B, Arnhold I J P, Jorge A A L
Abstract excerpt
Insulin-like growth factor type 1 (IGF1) is a mediator of growth hormone (GH) action, and therefore, IGF1 is a candidate gene for recombinant human GH (rhGH) pharmacogenetics. Lower serum IGF1 levels were found in adults homozygous for 19 cytosine-adenosine (CA) repeats in the IGF1 promoter. The aim of this study was to evaluate the influence of (CA)n IGF1 polymorphism, alone or in combination with GH receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.